29. februar 2024 ble 2024 Kina Binzhou (Shenzhen) Medical and Health Industry Investment and Cooperation Promotion Conference om "Shenzhen Xinglian Rong Binbin Diverse Future" holdt i Shenzhen.
Fan Daiming, an academician of the CAE Member, a foreign academician of the American Academy of Medical Sciences, and the former vice president of the Chinese Academy of Engineering, Li Liejun, a foreign academician of the Russian Academy of Engineering, a professor of South China University of Technology, and president of Guangdong Doctor Innovation and Development Promotion Association, Mei Yonghong, a director of Shenzhen Huada Group, chairman of Huada Agricultural Group, and president of Shenzhen Huagu Zhiyuan Biotechnology and Industry Research Institute, Bi Siliang, director of the office of the People's Government of Shandong Province in Guangzhou, Wang Lixin, president of Shenzhen Shandong Chamber of Commerce, Xu Jinkui, rotating president of Shenzhen Financial Chamber of Commerce, Zhang Fengchuan, Book of Shenzhen Pharmaceutical Industry Association, styreleder for Ruilide Biotechnology Co., Ltd., Wang Mingxing, konserndirektør for Shenzhen Research Institute of Shandong University, og Dashi Pharmaceutical Wabance Chunhe, grunnlegger og styreleder, og styreleder.
Representanter for farmasøytiske og helsebedrifter i Greater Bay Area, representanter for universiteter, forskning og utvikling, og finansinstitusjoner, representanter for bransjeforeninger og handelskamre, og representanter for kysttalenter i Greater Bay Area; Representanter for ledende farmasøytiske og helsebedrifter i Binzhou City, samt sentrale tjenestemenn fra forskjellige fylker, distrikter, kommunale avdelinger, parker, kommunale statseide foretak, relevante universiteter og medisinske institusjoner, deltok i arrangementet.
Shandong Zhonghuan Zhongjie Biotechnology Co., Ltd. ble invitert til å delta og signerte en kontrakt på stedet som et sentralt prosjekt for legemiddel- og helseindustrien i Greater Bay Area i Binzhou City.
